Ikonisys S.A. logo

Ikonisys S.A. (ALIKO)

Market Closed
10 Aug, 15:30
XPAR XPAR
1. 46
+0.01
+0.6897%
16.55M Market Cap
- P/E Ratio
- Div Yield
184 Volume
0 Eps
1.45
Previous Close
Add Transaction
Day Range
1.46 1.46
Year Range
1.36 1.84
Want to track ALIKO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ALIKO closed today higher at €1.46, an increase of 0.6897% from yesterday's close, completing a monthly decrease of -2.6667% or -€0.04. Over the past 12 months, ALIKO stock lost -6.4103%.
ALIKO is not paying dividends to its shareholders.
The last earnings report, released on Oct 31, 2023, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

ALIKO Chart

People also search for

GenSight Biologics S.A.
0.09
-2.1591%
Crossject SA Warrant
1.29
-3.0075%
EDI
Media 6 SA
9.89
0%
Trilogiq S.A.
5.1
-1.9231%
Advicenne S.A.
1.62
-2.6506%

Ikonisys S.A. (ALIKO) FAQ

What is the stock price today?

The current price is €1.46.

On which exchange is it traded?

Ikonisys S.A. is listed on XPAR.

What is its stock symbol?

The ticker symbol is ALIKO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 16.55M.

Has Ikonisys S.A. ever had a stock split?

No, there has never been a stock split.

Ikonisys S.A. Profile

Health Care Technology Industry
Healthcare Sector
Mr. Mario P. Crovetto CEO
XPAR Exchange
FR00140048X2 ISIN
FR Country
10 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Ikonisys S.A., established in 2021, is a cell-based diagnostics company that plays a significant role in the medical diagnostics industry, particularly focusing on cancer diagnostics. With operations both in the United States and Europe, the company specializes in the design, manufacturing, marketing, and sale of innovative medical diagnostic products. Its main objective is to advance cancer diagnostics through automation, precision, and accessibility, offering cutting-edge solutions that leverage the latest in cellular analysis technology.

Products and Services

  • Ikoniscope Robotic Microscope: This advanced system streamlines the diagnostic process by offering automated slide handling, scanning, and real-time image capture and analysis. It is designed to improve efficiency and accuracy in laboratory settings.
  • oncoFISH bladder: A diagnostic tool designed for the scanning and analysis of cells recovered from voided urine samples. This application aids in the early detection and monitoring of bladder cancer.
  • oncoFISH her2: A microscopy application specialized for the determination of HER2 status in tissue sections from breast tissue biopsies. This is crucial for identifying the appropriate treatment plan for breast cancer patients.
  • oncoFISH anaplastic lymphoma kinase (ALK): This application utilizes FISH (Fluorescence In Situ Hybridization) for the detection of rearrangements in the gene encoding anaplastic lymphoma kinase (ALK), relevant in certain types of non-small cell lung cancer.
  • oncoFISH PTEN: A microscopy application for the FISH-based detection of deletions in the PTEN gene within prostate tissue biopsies. This is important for prostate cancer diagnosis and understanding tumor behavior.
  • Circulating Tumor Cells: This technology facilitates the characterization of individual tumor cells, providing insights into the behavior and characteristics of various cancers.
  • Circulating Tumor DNA (ctDNA): Offers global tumor genotype information, which is crucial for understanding the genetic makeup of tumors and tailor treatment plans accordingly.
  • Ikonisoft Explorer CS: A FISH scanning application designed for the analysis of cell suspension deposited on a slide, which has been hybridized with a combination of FISH probes. This application is versatile for different types of cellular analyses.
  • Ikonisoft Explorer Tissue: Similar to the Explorer CS, this application is focused on the analysis of various tissue sections hybridized with a chosen combination of FISH probes, providing detailed insights into tissue-specific cancers.
  • IkoniWAN Gateway: A validated remote access solution that allows for the remote operation of Ikoniscope digital microscopy systems. This technological innovation enhances the accessibility and efficiency of cancer diagnostics by enabling pathologists and researchers to access and analyze samples from anywhere.

Contact Information

Address: 62 rue de Caumartin, Paris, France, 75009
Phone: 33 39 348 901 9064